Market revenue in 2020 | USD 19.7 million |
Market revenue in 2027 | USD 28.9 million |
Growth rate | 5.6% (CAGR from 2020 to 2027) |
Largest segment | Autosampler systems |
Fastest growing segment | Autosampler Systems |
Historical data | 2016 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2027 |
Quantitative units | Revenue in USD million |
Market segmentation | Autosampler Systems, Autosampler Accessories |
Key market players worldwide | IQVIA Holdings Inc, Icon PLC, Charles River Laboratories International Inc, Pharmaceutical Product Development |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to autosamplers market will help companies and investors design strategic landscapes.
Autosampler systems was the largest segment with a revenue share of 64.47% in 2020. Horizon Databook has segmented the Australia autosamplers market based on autosampler systems, autosampler accessories covering the revenue growth of each sub-segment from 2016 to 2027.
Australia is characters by presence of nearly 400 domestic biotechnology and around 500 MedTech companies as well as approximately 50 multinational companies operating as subsidiaries in Australia such as including Pfizer, GSK, Bristol-Myers Squibb, Merck, and Novartis. The presence of large number of local and foreign companies is anticipated to facilitate the manufacturing & research activities, thereby boosting the market growth.
Moreover, the tax benefits, government funding and stringent intellectual property rights in the country are anticipated to increase the market attractiveness of the country. For instance, in 2018, the country ranked 7th among the 135 countries listed on the International Property Rights Index. Supportive research activities undertaken in the country are anticipated to favor market growth.
The deadly nature of the pathogen coupled with the need for vaccine discovery is anticipated to expedite the drug testing and bioanalytical measures undertaken for drug approval which is expected to increase the adoption of advanced and automated equipment and thereby indirectly fuel the market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia autosamplers market, including forecasts for subscribers. This country databook contains high-level insights into Australia autosamplers market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account